Cite
Yang F, Zhu HL, He C, et al. Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study. Indian J Hematol Blood Transfus. 2012;30(2):97-104doi: 10.1007/s12288-012-0195-2.
Yang, F., Zhu, H. L., He, C., Li, J. J., Xiang, B., Cui, X., Huang, J., Ji, J., Ma, H. B., & Liu, T. (2014). Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 30(2), 97-104. https://doi.org/10.1007/s12288-012-0195-2
Yang, Fan, et al. "Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study." Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion vol. 30,2 (2014): 97-104. doi: https://doi.org/10.1007/s12288-012-0195-2
Yang F, Zhu HL, He C, Li JJ, Xiang B, Cui X, Huang J, Ji J, Ma HB, Liu T. Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study. Indian J Hematol Blood Transfus. 2014 Jun;30(2):97-104. doi: 10.1007/s12288-012-0195-2. Epub 2012 Oct 30. PMID: 24839363; PMCID: PMC4022915.
Copy
Download .nbib